-2.3 (-0.43%)
-1.45 (-0.27%) 8.56 am | 01 Dec 2011 | Source: CNBC-TV18
Vikas Dandekar of PharmAsiaNews.com tells CNBC-TV18 that the US FDA approval for Lipitor is definitely going to be a big positive for Ranbaxy....
11.55 am | 30 Nov 2011 | Source: CNBC-TV18
Chirag Talati, pharma analyst at Espirito Santo Securities tells CNBC-TV18 that Ranbaxy is most likely set to go ahead with the launch of the generic ...
1.05 pm | 21 Mar 2011 | Source: CNBC-TV18
The US Foods and Drugs Administration (USFDA) will be sued by the US pharmaceutical company Mylan Inc, for an injunction on the launch of Ranbaxy’s ch...
8.26 am | 27 Jan 2011 | Source: CNBC-TV18
Ranbaxy CFO, Omesh Sethi has resigned. PharmAsia News India Bureau Chief, Vikas Dandekar, speaks exclusively to CNBC-TV18’s Reema Tendulkar on the exi...
4.27 pm | 22 Jan 2011 | Source: CNBC-TV18
Kamal Sharma, Managing Director of Lupin, started four decades ago almost as a stockiest and C&F agent. Today, his company is one of India’s largest d...
10.10 pm | 04 Jan 2011 | Source: CNBC-TV18
Drug majors Ranbaxy and Merck have called off a deal that would have seen both the pharma giants join hands to research anti-infectives, reports Pharm...